Tranzyme and BD Technologies Strike Deal to Share Lab Space, Technology | GenomeWeb

NEW YORK, Sept. 10-Tranzyme has launched a research collaboration with BD Technologies, the two companies said today. Tranzyme also said today that it will also open a new lab for neurosensory disease research in BD Technologies' Research Triangle Park incubator.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.